logo

ARTL

Artelo Biosciences·NASDAQ
--
--(--)
--
--(--)

ARTL fundamentals

Artelo Biosciences (ARTL) released its earnings on Aug 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -16.83 (YoY -24.67%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-16.83
-24.67%
Report date
Aug 13, 2025
EPS
Q3,undefined
Q4,undefined
Q1,undefined
Q3,2020
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q1,2022
Q2,2022
Q3,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-72.9-59.4-37.8-29.7-27-21.6-15.66-14.76-13.68-10.08-14.94-17.82-14.04-13.5-6.3-21.06-12.96-16.83
Forecast
-108-97.2-27-31.05-18.9-14.85-15.3-15.9-19.8-13.95-11.64-10.02-17.64-14.28-14.265-7.86-2.3994-12.57
Surprise
0.00%
0.00%
0.00%
+32.50%
+38.89%
-40.00%
+4.35%
-42.86%
-45.45%
-2.35%
+7.17%
+30.91%
+27.74%
-28.35%
-77.84%
+20.41%
+5.46%
+55.84%
-167.94%
-440.14%
-33.89%
Revenue
Q3,undefined
Q4,undefined
Q1,undefined
Q3,2020
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q1,2022
Q2,2022
Q3,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
----------0000000000000--00
Forecast
------------000000000000000
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Earnings Call